CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T-cells
Riley M. Horvath, Ivan Sadowski
The paper shows that CBP/p300 inhibitors reverse HIV-1 latency in T-cells by altering acetylation at the HIV-1 LTR, and that this effect is distinct from HDACi mechanisms.
iScience · Oct 30, 2024Peer-reviewedMolecular Biology